<DOC>
	<DOCNO>NCT02533648</DOCNO>
	<brief_summary>Our recent data mice demonstrate key role xanthine oxidase hyperglycemia-induced Reactive oxygen specie production , preventive role allopurinol ( inhibitor xanthine oxidase ) keep mitochondria number structure , skeletal muscle diabetic mouse . The investigator want initiate clinical trial order evaluate efficacy allopurinol improvement mitochondrial alteration , oxidative capacity insulin sensitivity , skeletal muscle type 2 diabetic patient .</brief_summary>
	<brief_title>Role Allopurinol Oxidative Stress Mitochondrial Alterations Skeletal Muscle Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>BMI 25 40 kg/m² Type 2 diabetes know one year le 10 year , treat Oral antidiabetic drug Glucagonlike peptide1 ( GLP1analog ) well control hypertension ( untreated currently treat ) systolic blood pressure 95 140 mmHg diastolic blood pressure 45 90 mmHg heart frequency 40 100 per minute Recent HbA1c &lt; 9 % Uricemia &gt; 300 µmol/l For woman : Menopausal contraception Renal function define glomerular filtration rate ( GFR ) ≥ 80 mL/min/1.73 m2 Tobacco ( 5 cigarette ) Excessive drinking Known pathology Hypersensitivity allopurinol Treatment anticoagulant , allopurinol , regular steroid Nonsteroidal antiinflammatory drug ( NSAID ) , fibrate insulin</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Type 2 diabetes mellitus , oxidative stress</keyword>
	<keyword>insulin sensitivity</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>mitochondrial dysfunction</keyword>
	<keyword>skeletal muscle</keyword>
	<keyword>xanthine oxidase</keyword>
	<keyword>allopurinol</keyword>
</DOC>